Associate Professor, Surgery, Ohio State University College of Medicine
General Surgery
Dr. Lisa D. Yee, MD
|
|
Give Review
Lisa practices General Surgery. He researched medicine at Yale University School of Medicine. Yale University School of Medicine is a top medical university. Yale University School of Medicine is ranked 7 in research and 57 in primary care medicine He over the years received 2 awards: "CMS Meaningful Use Stage 1 Certification" and "Fellow (FACS)". Lisa is also published. He has 46 publications published. The lastest publication: "Phase I clinical and pharmacological studies of benzylacyclouridine, a uridine phosphorylase inhibitor.'
Publications
- Attachment anxiety is related to Epstein-Barr virus latency.
- Cognitive problems among Breast cancer survivors: loneliness enhances risk.
- Social support predicts inflammation, Pain, and depressive symptoms: Longitudinal relationships among breast cancer survivors.
- Beta-blockers may reduce intrusive thoughts in newly diagnosed Cancer patients.
- The inhibition of early stages of HER-2/neu-mediated mammary carcinogenesis by dietary n-3 PUFAs.
- A liquid chromatography-tandem mass spectrometric method for quantification of curcumin-O-glucuronide and curcumin in human plasma.
- Social support and socioeconomic status interact to predict Epstein-Barr virus latency in women awaiting diagnosis or newly diagnosed with Breast cancer.
- Enhancement of curcumin oral absorption and pharmacokinetics of curcuminoids and curcumin metabolites in mice.
- Fatigue and herpesvirus latency in women newly diagnosed with Breast cancer.
- Omega-3 fatty acid supplements in women at high risk of Breast cancer have dose-dependent effects on Breast adipose tissue fatty acid composition.
- Reproducibility of random periareolar fine needle aspiration in a multi-institutional Cancer and Leukemia Group B (CALGB) cross-sectional study.
- Clinical Use of PPARgamma Ligands in Cancer.
- Pilot study of rosiglitazone therapy in women with Breast cancer: effects of short-term therapy on tumor tissue and serum markers.
- Prospective randomized clinical trial comparing intradermal, intraparenchymal, and subareolar injection routes for sentinel lymph node mapping and biopsy in Breast can...
- Dietary (n-3) polyunsaturated fatty acids inhibit HER-2/neu-induced Breast cancer in mice independently of the PPARgamma ligand rosiglitazone.
- Patterns of recurrence after sentinel lymph node biopsy for Breast cancer.
- The flavonoid, naringenin, decreases adipose Tissue mass and attenuates ovariectomy-associated metabolic disturbances in mice.
- Rat Muc4 (sialomucin complex) reduces binding of anti-ErbB2 antibodies to tumor cell surfaces, a potential mechanism for herceptin resistance.
- Phase I trial of weekly paclitaxel in advanced lung Cancer.
- The syndrome of inappropriate secretion of antidiuretic hormone (SIADH) as a consequence of neck dissection.
- Tissue and tumor expression of a cell surface glycoprotein complex containing an integral membrane glycoprotein activator of p185neu.
- Phase I clinical and pharmacological studies of benzylacyclouridine, a uridine phosphorylase inhibitor.
- Methylation of adjacent CpG sites affects Sp1/Sp3 binding and activity in the p21(Cip1) promoter.
- Selective Analysis of the sentinel node in breast cancer.
- Localization and functional parameter reconstruction of suspicious Breast lesions by near infrared/ultrasound dual modal imaging.
- Reprogramming of the tumour microenvironment by stromal PTEN-regulated miR-320.
- The constitutive production of colony stimulating factor 1 by invasive human Breast cancer cells.
- Pten in stromal fibroblasts suppresses mammary epithelial tumours.
- TGF-beta inhibition of CTL re-stimulation requires accessory cells and induces peroxisome-proliferator-activated receptor-gamma (PPAR-gamma).
- CBP/p300 induction is required for retinoic acid sensitivity in human mammary cells.
- Oncogene structure, function, and expression in Breast cancer.
- Peroxisome proliferator-activated receptor gamma activation in human Breast cancer.
- Routine preoperative lymphoscintigraphy is not necessary prior to sentinel node biopsy for Breast cancer.
- Predictors of positive axillary lymph nodes after sentinel lymph node biopsy in Breast cancer.
- Morphologically normal-appearing mammary epithelial cells obtained from high-risk women exhibit methylation silencing of INK4a/ARF.
- Hypermethylation of the Breast cancer-associated gene 1 promoter does not predict cytologic atypia or correlate with surrogate end points of Breast cancer risk.
- Retinoids and retinoic acid receptors regulate growth arrest and apoptosis in human mammary epithelial cells and modulate expression of CBP/p300.
- Retinoic acid receptor-beta2 promoter methylation in random periareolar fine needle aspiration.
- Human Breast carcinoma cell levels of MDR-1 (P-glycoprotein) transcripts correlate in vivo inversely and reciprocally with tumor progesterone receptor content.
- Ovarian adenoCarcinomas express fms-complementary transcripts and fms antigen, often with coexpression of CSF-1.
- Phase II trial of neoadjuvant chemotherapy with docetaxel followed by epirubicin in stage II/III Breast cancer.
- Suppression of pRB expression in normal human mammary epithelial cells is associated with resistance to all-trans-retinoic acid but not N-(4-hydroxylphenyl)-retinamide.
- The antiproliferative effects of PPARgamma ligands in normal human mammary epithelial cells.
- Re-emphasizing the concept of adequacy of intraoperative assessment of the axillary sentinel lymph nodes for identifying nodal positivity during Breast cancer surgery.
- FMS (CSF-1 receptor) and CSF-1 transcripts and protein are expressed by human Breast carcinomas in vivo and in vitro.
Schools
Yale University School Of Medicine
Mt Sinai Med Center Of Fl
Or Health Science University Hospital
Procedures Preformed
- Biopsy of Breast
- Breast Reconstruction
- Excision of Breast Tumor
- Excision, Shaving, or Destruction of Skin and Subcutaneous Tissue (incl. Mohs Micrographic Surgery), Tissue Transfer
- View All
Conditions Treated
- Abdominal Pain
- Anal Fissure
- Anorectal Abscess
- Breast Cancer
- View All
Doctors Specialties
- General Surgery
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Anthem Blue Cross Blue Shield HMO
- Anthem Blue Cross Blue Shield PPO
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Cofinity PPO
- Coventry Health America PPO
- First Health (Coventry Health Care) PPO
- Medical Mutual of Ohio POS
- MultiPlan PPO
- PHCS Network PPO
- Mutual of Omaha
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACS)
Education
-
Mount Sinai Medical Center of Florida -
Oregon Health & Science University -
Yale University School of Medicine
Hospital
-
Ohio State University Wexner Medical Center
Drug Facts
| NPI NUMBER | 1730129834 | |
| NPPES Provider LastName | YEE | |
| NPPES Provider FirstName | LISA | |
| NPPES Provider ZIPCode | 432123117 | |
| NPPES Provider State | OH | |
| Specialty Description | Surgical Oncology | |
| Total Claim Count | 27.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1730129834 |
| Last Name Of The Provider | YEE |
| First Name Of The Provider | LISA |
| View All |
Similar Doctors
|
Dr. David B. Renton, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Denis R. King, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Mitchell L. Henry, MD |
|
Dr. Keith E. Nichols, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Charles W. Taylor III, MD |
|
|
Dr. Eliza W. Beal, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stephanie N. Buchanan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ronald M. Ferguson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Valerie P. Grignol, MD |
|
|
Dr. Michael S. O'Mara, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Terrence M. Rager, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brian R. Williams, MD |